Commentary: Ending the 340B Profit Loophole

Posted
As a physician and veteran, I am driven by a duty to serve and a commitment to doing what is right. In the military, we understood that every resource must be optimized for the mission. In medicine, we are taught that our primary duty is to the patient. Unfortunately, the federal 340B Drug Pricing Program, originally designed to help safety-net providers stretch scarce resources to serve the vulnerable, has strayed far from this noble objective. What was once a targeted and compassionate initiative has morphed into a massive, unchecked profit engine for non-profit hospitals. Congress created the 340B program in 1992 to require pharmaceutical manufacturers to provide steep drug discounts to hospitals serving low-income communities. The goal was simple: use the savings to subsidize care for the uninsured and under-insured. Today, however, many nonprofit hospitals use the program to engage in a lucrative form of arbitrage—purchasing medications at deep discounts and billing insurers at full price, pocketing the massive spread.

Continue reading at Tennessee Star »

Policy, News, Commentary, 340B Drug Pricing Program, hospitals, military, Omar Hamada, Tax Exempt Hospital Transparency Act